Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer
about
Survivin: a unique target for tumor therapyWhen Prostate Cancer Circulates in the BloodstreamExtracellular vesicle transfer of cancer pathogenic componentsPSA and beyond: alternative prostate cancer biomarkersTumor-derived exosomes in cancer progression and treatment failureLocalization and upregulation of survivin in cancer health disparities: a clinical perspectiveMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersExosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression.Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomesExtracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugsThe pre-metastatic niche: finding common ground.Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cellsProteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progressionMicroparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.Early diagnostic value of survivin and its alternative splice variants in breast cancer.Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis.Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survivalThe emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.The emerging role of exosomes in survivin secretion.Exosomes in cancer: small particle, big player.Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer PatientsProstasomes as a source of diagnostic biomarkers for prostate cancer.Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.Pancreatic cancer diagnosis by free and exosomal miRNA.Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.Extracellular vesicles in prostate cancer: new future clinical strategies?Monitoring survivin expression in cancer: implications for prognosis and therapy.The roles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers.The potential of exosomes in diagnosis and treatment of inborn errors of metabolism.Extracellular RNA mediates and marks cancer progression.Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle.The emerging role of extracellular vesicles as biomarkers for urogenital cancers.Tracing Cellular Origin of Human Exosomes Using Multiplex Proximity Extension Assays.Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
P2860
Q26747332-9AECEF0D-5535-4AAA-A55C-8DBABD9FC41DQ26768470-8F022107-D798-4E15-9CAF-744B670388BEQ26770045-E1CB88E9-370F-4098-95BC-3ECD3A4B4EC2Q26770646-A4085DD6-6FFD-47CD-A2BE-80CBB94F2C98Q26785408-EB6D4341-CAD6-4D70-AC43-7A84DEF6F6A2Q26799719-5604E529-1A23-4904-B8AE-221A3ADC5F6BQ26822406-840A0B49-0766-4A88-A87A-F6372FA70168Q33363486-406E5533-BC74-4888-8AC1-A6C1127B6859Q33670207-B027EDC9-426A-4ADD-8204-EA54DB618D27Q34040540-A27040EE-6368-4C59-B013-F1399E61D14CQ34106619-581F3FAD-F11B-4481-A42D-5BE1ACB0BD86Q34304788-6F2F6428-6F74-4805-9B89-1EE7B928C07FQ34342357-52674BD6-4F04-46A7-8CF1-6B388F8D0D74Q34712380-E292D8DE-9DC9-4B48-BC03-BFFE3A069AF6Q34999444-2BE79E17-ED63-4116-AF3C-9337D3C2888EQ35051303-45D291F0-317E-41AA-899A-D0375766841AQ35118374-C9921C43-88DE-41E0-BFCC-A1ACBC8347CFQ35440744-7678E331-3C4C-4C87-9B07-72F80C0A960BQ35763548-D79E382A-2DF6-4F31-9D44-9A94984F287FQ35798846-65B44C1C-4603-4165-8455-BA1BDDC66187Q35807725-9A1FD73D-4653-4917-8082-8AF82125BCC8Q35810533-6F17D5E1-06FD-4D88-AC51-7DE6873FB15BQ35834473-2F73C855-6968-461E-B584-15659999730FQ36010700-C7DE6D33-92CF-456D-9941-C57AC4A0FF7DQ36520462-B17D831A-DBE4-4CEF-A460-27833989A6ABQ36737927-63EA2B92-7646-4B1D-8757-A4570CC6AE59Q36772138-251BD6DA-CF6A-4176-80D6-1B4ACC265C7FQ37382231-FE76E960-2727-4968-B8E9-3D7F7F825C6DQ37507018-A0A0B1B4-8F24-4AF1-91D8-FC7DC2382CDEQ37593002-BCDCB506-1671-41B5-8B3A-976CC59C2F92Q37632337-3D30C87E-5F6E-47A6-B499-F9D8C99DC9D1Q38126394-03A9D517-51D4-4E20-AB11-42A556389070Q38171466-2B29FD7C-3CE9-4FA5-A7E7-4E92D8AB375BQ38186575-851D8354-AA47-47ED-A2BE-41DDE0EE2157Q38208372-24A6D7FE-EC47-4B1C-AC5F-730171ACED53Q38217593-17490721-9E4C-4D3D-A01C-DC7E32F0A233Q38264347-1E91F009-3F9B-4A85-A979-5568E6FB76F9Q38268801-3749FACB-010E-45CC-987F-824DC0DC4E9DQ38374002-A26C216E-56B6-43AF-B0E4-883C48C8716DQ38378261-5C4B9251-7D54-4820-9B34-5557F369B2F3
P2860
Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@ast
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@en
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@nl
type
label
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@ast
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@en
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@nl
prefLabel
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@ast
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@en
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@nl
P2093
P2860
P1433
P1476
Plasma-derived exosomal surviv ...... y detection of prostate cancer
@en
P2093
Arjun Ashok
Dan Mercola
David Turay
Jonathan R Aspe
Malyn May A Valenzuela
Michael B Lilly
Saied Mirshahidi
Salma Khan
P2860
P304
P356
10.1371/JOURNAL.PONE.0046737
P407
P577
2012-10-16T00:00:00Z